Brookline, MA, United States of America

Matthew Christopher


 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Wallingford, CT (US) (2013)
  • Brookline, MA (US) (2013 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovative Mind of Matthew Christopher

Introduction

Matthew Christopher, based in Brookline, MA, is a prominent inventor recognized for his significant contributions to medical research and development. With an impressive portfolio of 18 patents, he has made remarkable strides in the field of pharmaceutical innovation, particularly in developing treatments for serious health conditions.

Latest Patents

Among Matthew's latest inventions are purine inhibitors of human phosphatidylinositol 3-kinase delta. These patented compounds, referred to as formulas Ia and Ib, serve as PI3K-delta inhibitors and are instrumental in treating diseases mediated by this pathway, such as inflammation, asthma, chronic obstructive pulmonary disease (COPD), and cancer. His expertise is reflected in his recent patents, which collectively address critical healthcare challenges and offer promising therapeutic options.

Career Highlights

Matthew's career spans notable positions at renowned biopharmaceutical companies, specifically Merck Sharp & Dohme Corporation and Merck Canada Inc. Throughout his tenure, he has been at the forefront of innovative research, driving projects that intersect biotechnology and pharmacology. His work has earned him recognition in the scientific community, solidifying his reputation as an inventive force.

Collaborations

In the course of his career, Matthew has collaborated with respected professionals in the industry, including Michael D. Altman and Michael Hale Reutershan. These partnerships have not only facilitated the advancement of his inventions but also contributed to a collaborative spirit in the research environment, leading to greater innovation and discovery.

Conclusion

Matthew Christopher exemplifies the essence of innovation in the pharmaceutical realm. His patents demonstrate a commitment to addressing significant health issues through scientific research and technological advancements. As a dedicated inventor, Matthew continues to pave the way for new treatments that have the potential to change lives for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…